Aviva’s NovoCure NVCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-87,041
Closed -$3.61M 1004
2023
Q2
$3.61M Sell
87,041
-115,318
-57% -$4.79M 0.01% 554
2023
Q1
$12.2M Buy
202,359
+1,929
+1% +$116K 0.06% 435
2022
Q4
$14.7M Buy
200,430
+120,871
+152% +$8.87M 0.07% 373
2022
Q3
$6.05M Sell
79,559
-29,516
-27% -$2.24M 0.03% 538
2022
Q2
$7.58M Buy
109,075
+82,524
+311% +$5.74M 0.04% 499
2022
Q1
$2.2M Sell
26,551
-3,931
-13% -$326K 0.01% 807
2021
Q4
$2.29M Sell
30,482
-802
-3% -$60.2K 0.01% 844
2021
Q3
$3.63M Sell
31,284
-7,546
-19% -$877K 0.02% 661
2021
Q2
$8.61M Sell
38,830
-4,842
-11% -$1.07M 0.04% 433
2021
Q1
$5.77M Buy
43,672
+29,930
+218% +$3.96M 0.03% 492
2020
Q4
$2.38M Sell
13,742
-8,154
-37% -$1.41M 0.01% 646
2020
Q3
$2.44M Sell
21,896
-17,685
-45% -$1.97M 0.01% 611
2020
Q2
$2.35M Sell
39,581
-14,476
-27% -$858K 0.01% 618
2020
Q1
$3.64M Buy
+54,057
New +$3.64M 0.03% 565